Ultraviolet A Combined with Narrow-Band Ultraviolet B is an Effective Treatment Modality for Early Folliculotropic Mycosis Fungoides and Early Mycosis Fungoides Refractory to Narrow-Band Ultraviolet B: A Retrospective Cohort Study

Table 1

Characteristics of patients with early-stage mycosis fungoides treated with UVA combined with NBUVB.

Type of MF	Gender/age^#, median (range)	Stage of disease	Treatments prior to UVA + NBUVB and response
FMF: 39 patients	M-24, F-15/; 44 y (4–82)	IA-17; IB-22	Topical application: TCS: all; mechlorethamine gel: 2 SD; Phototherapy: NBUVB: 8 (6 PR, 2 SD); systemic PUVA: 1 CR; Other treatments: acitretin, IFN α: 1 SD; MTX: 2 SD; LEB: 1 CR
Non-FMF: 12 patients	M-9, F-3/; 50 y (7–83)	IA-2; IB-9; IIA-1	Topical application: TCS: all; mechlorethamine gel: 3 (2 SD, 1 stopped^&); Phototherapy: NBUVB: 9 (6 PR, 3 SD); systemic PUVA: 1 CR; Other treatments: MTX: 1 SD

CR, complete response; F, female; FMF, folliculotropic mycosis fungoides; IFN α, interferon α; LEB, localized electron beam; M, male; MTX, methotrexate; MF, mycosis fungoides; NBUVB, narrow-band ultraviolet B; PR, partial response; PUVA, psoralen plus ultraviolet A; SD, stable disease; TCS, topical corticosteroids; UVA, ultraviolet A; y, years. ^#Age at initiation of UVA and NBUVB. One patient had relatively thick plaques. ^&Stopped treatment due to contact dermatitis.